[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336633-105":59,"doc-detail-336633-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-dpyd-and-the-effects-of-dpyd-suppressor-luteolin-combined-with-5-fu-in-pancreatic-cancer","The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer","","Despite treatment advances, pancreatic ductal adenocarcinoma (PDAC) remains highly lethal due to limited effective therapies. Prior work showed luteolin suppresses pancreatocarcinogenesis and reduces dihydropyrimidine dehydrogenase (DPYD), an enzyme degrading pyrimidines including 5-fluorouracil (5-FU). This study evaluates DPYD roles and the therapeutic potential of combining 5-FU with luteolin in PDAC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-dpyd-and-the-effects-of-dpyd-suppressor-luteolin-combined-with-5-fu-in-pancreatic-cancer/336633/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-dpyd-and-the-effects-of-dpyd-suppressor-luteolin-combined-with-5-fu-in-pancreatic-cancer/336633.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does DPYD play in pancreatic cancer biology?","Question",{"text":112,"@type":113},"DPYD expression contributes to increased proliferation and invasiveness in PDAC and is associated with resistance to 5-FU.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does combining luteolin with 5-FU affect PDAC models?",{"text":117,"@type":113},"Single treatments with 5-FU or luteolin showed no significant inhibition, but the combined administration produced significant tumor-suppressive effects in both xenograft tumors and KPPC mice models.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is luteolin investigated alongside 5-FU in this study?",{"text":121,"@type":113},"Luteolin was previously shown to suppress pancreatocarcinogenesis and reduce DPYD expression, motivating evaluation of its ability to enhance 5-FU therapeutic efficacy in PDAC.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336633,1790077473,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","DOI: 10. 1002/cam4 .70124  \nRESEAR CH ARTICLE  \nThe role ofDPYD and the effects ofDPYD suppressor luteolin combined with 5-FU in pancreatic cancer  \nHiroyuki Kato1  | Motonori Sato1 | Aya Naiki-Ito1 | Shingo Inaguma1 | Makoto Sano2  | Masayuki Komura1 | Yuko Nagayasu1 | Kuang Xiaochen1 | Akihisa Kato3  | Yoichi Matsuo4 | Hideaki Ijichi5 | Satoru Takahashi1  \n1Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan  \n2Department of Anesthesiology, Nihon University School of Medicine, Tokyo, Japan  \n3Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan 4Department of Gastroenterology Surgery, Nagoya City University Graduate School of Medical Sciences and Medical School, Nagoya, Japan 5Department of Clinical Nutrition Center, Graduate School of Medicine, the University of Tokyo, Hongo, Tokyo, Japan  \nCorrespondence  \nHiroyuki Kato, Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1-Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. [Email:](Email: h.kato@med.nagoya-cu.ac.jp)[ h.kato@med.nagoya-cu.ac.jp](Email: h.kato@med.nagoya-cu.ac.jp)  \nAbstract  \nBackground: Despite advances in the treatment of cancer, pancreatic ductaladenocarcinoma (PDAC) remains highly lethal due to the lack of effective therapies. Our previous study showed that Luteolin (Lut), a flavonoid, suppressed pancreatocarcinogenesis and reduced the expression of dihydropyrimidine dehydrogenase (DPYD), an enzyme that degrades pyrimidines such as 5-fluorouracil (5-FU), in PDACs. In this study, we investigated the role of DPYD and evaluated the therapeutic potential of combining 5-FU with Lut in PDACs.  \nMethods and Results: PDAC cells overexpressing DPYD showed increased proliferation, and invasiveness, adding to the resistance to 5-FU. The xenograft tumors of DPYD-overexpressing PDAC cells also exhibit enhanced growth and invasion compared to the control xenograft tumors. RNA-seq analysis of the DPYD-overexpressing PDACxenograft tumors revealed an upregulation of genes associated with metallopeptidase activity—MMP9 and MEP1A. Furthermore, the overexpression of MEP1A in PDAC was associated with invasion. Next, we investigated the combined effects ofLut, a DPYD suppressor, and 5-FU on DPYDoverexpressing xenograft tumors and PDAC of Pdx1-Cre; LSL-KrasG12D/+; Trp53flox/flox(KPPC) mice. Neither single administration of 5-FU nor Lut showed significant inhibitory effects; however, the combined administration of 5-FU and Lut exhibited a significant tumor-suppressive effect in both the xenograft tumorsand KPPC models.  \nConclusion: We have elucidated that DPYD expression contributes to proliferation, invasiveness, and 5-FU resistance, in PDACs. The combination therapy of Lut and 5-FU holds the potential for enhanced efficacy against PDACs.  \nKEYWORDS  \n5-fluorouracil, combination drug therapy, dihydropyrimidine dehydrogenase, luteolin, pancreatic cancer  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2024 The Author(s). Cancer Medicine published by John Wiley & Sons Ltd.  \nCancer Medicine. 2024;13:e70124 .  \n[https://doi.org/10.1002/cam4.70124](https://doi.org/10.1002/cam4.70124)  \n[wileyonlinelibrary.com/journal/cam4](wileyonlinelibrary.com/journal/cam4)  \n1 of 11  \n1 | INTRODUCTION  \nPancreatic cancer remains a lethal disease with a 5-year survival rate of approximately 10%, despite advances in treatment that have improved the 5-year survival rate for various type of cancer.1 In Japan, there were 43,865 new cases of pancreatic cancer reported in 2019, with 37,677 deaths due to pancreatic cancer in 2020.2 The limited effectiveness of newly developed immunotherapies an","cbCaij6FlVc05bbr","https://ap.wps.com/l/cbCaij6FlVc05bbr","pdf",8356178,11,"English","# Introduction\n## Background and treatment challenges\n## Prior findings on luteolin and DPYD\n# Methods and Results\n## DPYD overexpression effects on proliferation, invasion, and 5-FU resistance\n## Xenograft findings and RNA-seq targets\n## Combined luteolin and 5-FU effects in xenograft and KPPC models\n# Conclusion","[{\"question\":\"What role does DPYD play in pancreatic cancer biology?\",\"answer\":\"DPYD expression contributes to increased proliferation and invasiveness in PDAC and is associated with resistance to 5-FU.\"},{\"question\":\"How does combining luteolin with 5-FU affect PDAC models?\",\"answer\":\"Single treatments with 5-FU or luteolin showed no significant inhibition, but the combined administration produced significant tumor-suppressive effects in both xenograft tumors and KPPC mice models.\"},{\"question\":\"Why is luteolin investigated alongside 5-FU in this study?\",\"answer\":\"Luteolin was previously shown to suppress pancreatocarcinogenesis and reduce DPYD expression, motivating evaluation of its ability to enhance 5-FU therapeutic efficacy in PDAC.\"}]","The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer | PDF",1790015957,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b532f140c22fbbfc651e5889e74a7f6.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb311328015c3e357825c899fd014e99.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/627de77c7e66b76a03866a8aafd0258c.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6b81152d702070087e95846c5b73b77.webp",980,1287]